You are here: Info > Legislation > Greek Pharmacovigilance Legislation
Circular regarding the management and reporting of safety issues in the context of conducting clinical trials 12976 05-02-2019
Read More
Announcement of the Department of Adverse Events / Directorate of Pharmaceutical Studies and Research on regulation regarding literature and signal management.
Common/frequently asked questions about Pharmacovigilance of medicines for human use and Materiovigilance.
National Organization for Medicines – Yellow Card
National Organization for Medicines Circular 64745/7-7-2014
Ministerial Decision 3a/90023, published in Government Gazette issue 2485/B/3-10-2013
National Organization for Medicines Circular 70473 01-10-2013
Ministerial Decision 3a/32221, published in Government Gazette issue 1049/B/29-4-2013
Announcement of National Organization for Medicines 29-04-2013
National Organization for Medicines Circular 82798 22-11-2012
Announcement of National Organization for Medicines 24-10-2012
National Organization for Medicines Circular 67585 26-09-2011
Summary of the Obligations for Marketing Authorization Holders of Medicinal Products & for Clinical Studies’ Sponsors
